2017
DOI: 10.4166/kjg.2017.70.5.247
|View full text |Cite
|
Sign up to set email alerts
|

Feasibility of Temporary Pancreatic Stenting after Early Endoscopic Retrograde Cholangiopancreatography in Patients with Acute Biliary Pancreatitis

Abstract: Background/Aims: To assess the safety and effectiveness of temporary pancreatic stenting after early endoscopic retrograde cholangiopancreatography (ERCP) in patients with acute biliary pancreatitis regardless of the severity or concomitant cholangitis. Methods: Temporary pancreatic stenting was performed in 79 patients with visualized pancreatic duct during ERCP. The outcomes of 64 patients with adequate pancreatic stenting (PS) and 15 patients with inadequate pancreatic stenting (no PS) were compared in this… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 37 publications
0
1
0
Order By: Relevance
“…Linear regression analysis revealed that there was a positive correlation between SEPC content and HCC tumour diameter in differently differentiated specimens (P < 0:01). Hepatocarcinogenesis was determined by an unbalanced angiogenesis process with augmented production of proangiogenic factors (drivers of vessel growth and maturation) by tumour cells and adjacent cells, including VEGF, platelet-derived growth factor [36][37][38]. Tumour size Stem Cells International was closely related to tumour angiogenesis, which provided the nutrition-carrying blood for tumour growth.…”
Section: Discussionmentioning
confidence: 99%
“…Linear regression analysis revealed that there was a positive correlation between SEPC content and HCC tumour diameter in differently differentiated specimens (P < 0:01). Hepatocarcinogenesis was determined by an unbalanced angiogenesis process with augmented production of proangiogenic factors (drivers of vessel growth and maturation) by tumour cells and adjacent cells, including VEGF, platelet-derived growth factor [36][37][38]. Tumour size Stem Cells International was closely related to tumour angiogenesis, which provided the nutrition-carrying blood for tumour growth.…”
Section: Discussionmentioning
confidence: 99%